Ibrexafungerp (MK 3118) is an orally active beta-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections[1].
Molecular Weight:
730.03
Purity:
99.83
CAS Number:
[1207753-03-4]
Formula:
C44H67N5O4
Target:
Fungal
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted